INR 85.47
(-0.13%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.01 Billion INR | -36.31% |
2022 | 1.59 Billion INR | 10.15% |
2021 | 1.44 Billion INR | 30.64% |
2020 | 1.1 Billion INR | 3.7% |
2019 | 1.06 Billion INR | -20.92% |
2018 | 1.34 Billion INR | 37.2% |
2017 | 982.4 Million INR | 15.27% |
2016 | 852.26 Million INR | 1.35% |
2015 | 840.88 Million INR | 30.88% |
2014 | 642.48 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 230.47 Million INR | -26.4% |
2023 Q2 | 406.67 Million INR | 14.48% |
2023 FY | 1.01 Billion INR | -36.31% |
2023 Q1 | 355.24 Million INR | -9.4% |
2023 Q3 | 444.78 Million INR | 9.37% |
2023 Q4 | 313.13 Million INR | -29.6% |
2022 Q4 | 392.11 Million INR | -2.84% |
2022 Q1 | 401.03 Million INR | -1.22% |
2022 Q2 | 393.83 Million INR | -1.79% |
2022 FY | 1.59 Billion INR | 10.15% |
2022 Q3 | 403.58 Million INR | 2.48% |
2021 Q4 | 405.97 Million INR | 6.68% |
2021 FY | 1.44 Billion INR | 30.64% |
2021 Q1 | 297.15 Million INR | 65.81% |
2021 Q3 | 380.53 Million INR | 5.8% |
2021 Q2 | 359.68 Million INR | 21.04% |
2020 Q2 | 293.53 Million INR | 5.12% |
2020 Q3 | 353.31 Million INR | 20.37% |
2020 FY | 1.1 Billion INR | 3.7% |
2020 Q4 | 179.2 Million INR | -49.28% |
2020 Q1 | 279.24 Million INR | 145.09% |
2019 Q1 | 304.04 Million INR | 2.51% |
2019 Q2 | 320.44 Million INR | 5.4% |
2019 FY | 1.06 Billion INR | -20.92% |
2019 Q4 | 113.93 Million INR | -65.21% |
2019 Q3 | 327.51 Million INR | 2.2% |
2018 Q4 | 296.59 Million INR | -27.69% |
2018 Q2 | 347.01 Million INR | 17.99% |
2018 Q1 | 294.09 Million INR | 71.97% |
2018 FY | 1.34 Billion INR | 37.2% |
2018 Q3 | 410.19 Million INR | 18.21% |
2017 Q4 | 171.01 Million INR | -40.73% |
2017 Q3 | 288.55 Million INR | 5.47% |
2017 Q1 | 250.13 Million INR | 0.0% |
2017 Q2 | 273.58 Million INR | 9.38% |
2017 FY | 982.4 Million INR | 15.27% |
2016 FY | 852.26 Million INR | 1.35% |
2015 FY | 840.88 Million INR | 30.88% |
2014 FY | 642.48 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 93.616% |
Aurobindo Pharma Limited | 39.23 Billion INR | 97.418% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 91.297% |
Granules India Limited | 7.18 Billion INR | 85.895% |
Indoco Remedies Limited | 4.74 Billion INR | 78.667% |
Achyut Healthcare Limited | 1.6 Million INR | -62861.964% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.674% |
Alkem Laboratories Limited | 32.83 Billion INR | 96.915% |
Alpa Laboratories Limited | 156.14 Million INR | -548.785% |
Brooks Laboratories Limited | 51.18 Million INR | -1879.402% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 61.042% |
Bajaj HealthCare Limited | 985.34 Million INR | -2.813% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 28.619% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.943% |
Eris Lifesciences Limited | 4.94 Billion INR | 79.505% |
FDC Limited | 5.34 Billion INR | 81.059% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 98.501% |
Gufic Biosciences Limited | 1.07 Billion INR | 5.999% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 52.308% |
Ipca Laboratories Limited | 13.91 Billion INR | 92.72% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -30.986% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2094.857% |
Lasa Supergenerics Limited | 291.17 Million INR | -247.922% |
Laurus Labs Limited | 3.01 Billion INR | 66.353% |
Lupin Limited | 95.67 Billion INR | 98.941% |
Mankind Pharma Limited | 23.15 Billion INR | 95.624% |
Medicamen Biotech Limited | 335.16 Million INR | -202.255% |
Medico Remedies Limited | 161.84 Million INR | -525.947% |
Megasoft Limited | 49.52 Million INR | -1945.425% |
NATCO Pharma Limited | 10.05 Billion INR | 89.928% |
Piramal Pharma Limited | 19.91 Billion INR | 94.913% |
RPG Life Sciences Limited | 1.63 Billion INR | 38.058% |
Sigachi Industries Limited | 579.88 Million INR | -74.699% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.343% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 27.783% |
Syncom Formulations (India) Limited | 942.39 Million INR | -7.498% |
Unichem Laboratories Limited | 6.72 Billion INR | 84.938% |
Wanbury Limited | 1.16 Billion INR | 12.737% |
Windlas Biotech Limited | 1 Billion INR | -0.651% |
Zydus Lifesciences Limited | 43.17 Billion INR | 97.654% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 67.074% |
Divi's Laboratories Limited | 14.17 Billion INR | 92.851% |
Hester Biosciences Limited | 908.84 Million INR | -11.467% |
Procter & Gamble Health Limited | 2.99 Billion INR | 66.18% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 7.819% |
Bal Pharma Limited | 389.89 Million INR | -159.832% |
Strides Pharma Science Limited | 9.16 Billion INR | 88.943% |
Venus Remedies Limited | 1.91 Billion INR | 47.134% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 67.049% |
Nectar Lifesciences Limited | 625.55 Million INR | -61.947% |
Shilpa Medicare Limited | 2.18 Billion INR | 53.542% |
Aarti Drugs Limited | 1.16 Billion INR | 13.227% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 7.803% |
Suven Life Sciences Limited | 109.75 Million INR | -823.06% |
Ind-Swift Limited | 946.56 Million INR | -7.024% |
Valiant Laboratories Limited | 36.28 Million INR | -2691.639% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 87.964% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 77.879% |
Themis Medicare Limited | 782.85 Million INR | -29.406% |
Hikal Limited | 2.48 Billion INR | 59.255% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.271% |
Sequent Scientific Limited | 2.9 Billion INR | 65.089% |
Novartis India Limited | 470.1 Million INR | -115.498% |
Wockhardt Limited | 6.4 Billion INR | 84.171% |
Jubilant Pharmova Limited | 14.45 Billion INR | 92.991% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -6149.703% |
Neuland Laboratories Limited | 2.92 Billion INR | 65.422% |
Morepen Laboratories Limited | 1.98 Billion INR | 49.027% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -145.633% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | -49.828% |